CBS HEALTH VIDEO:
Dr. Rudy Tanzi heads the world-famous Alzheimer’s Genome Project. See him describe science-based techniques to reduce Alzheimer’s risk and protect your brain.
SOURCE:
CBS HEALTH VIDEO:
Dr. Rudy Tanzi heads the world-famous Alzheimer’s Genome Project. See him describe science-based techniques to reduce Alzheimer’s risk and protect your brain.






This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To

GOOD NEWS: Donepezil (Aricept®), approved for Alzheimer’s, also passed a long-term trial for Dementia with Lewy Bodies (DLB). Get the details on the medicine’s positive

DIAGNOSIS: Learn to spot Lewy body dementia (LBD). LBD is the most common type of dementia after Alzheimer’s. Find out the symptoms that make LBD different.

FDA clears AIRAscore to diagnose and manage many types of dementia. See how it detects and tracks subtle brain volume changes.

The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On